Now showing items 1-9 of 9
CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis
(Wiley Subscription Services, Inc., A Wiley Company, 2007-05)
Objective In diffuse parenchymal lung diseases, the evolution of pulmonary fibrosis is often devastating and may result in death. In this study the role of CCL18 as a biomarker of disease activity in idiopathic interstitial ...
The network structure of critical care transfers, 1993
(Society for Critical Care Medicine Annual Meeting, 2007-02)
Background: In light of wide variations between
hospitals in their quality of critical care, some
have proposed moving patients to better
quality. A system of critical care transfers
already exists, but it is little ...
Current and Emerging Strategies for the Management of Sarcoidosis
(Informa Healthcare USA (NY), 2007)
Diversity of the angiogenic phenotype in non-small cell lung cancer
(American Thoracic Society, 2007)
An essential role for CCAAT/enhancer binding protein Β in bleomycin-induced pulmonary fibrosis No conflicts of interest were declared.
(John Wiley & Sons, Ltd., 2007-03)
Pulmonary fibrosis is characterized by inflammation, genesis of myofibroblasts, and abnormal tissue repair. Despite extensive research, its pathogenesis remains incompletely understood. Previously, the transcription factor ...
PGE2 inhibition of TGF-_1 induced fibroblast to myofibroblast differentiation is SMAD-independent, but involves cell shape and adhesion-dependent signaling
(American Physiological Society, 2007)
TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response
(WILEY-VCH Verlag, 2007-10)
Type 1 (Th1) granulomas can be studied in mice sensitized with mycobacterium antigens followed by challenge of agarose beads covalently coupled to purified protein derivative. TLR9 is known to play a role in the regulation ...